Max Robotics — Global Service Robot Directory + US Certification

About

Simon Engelmann is a urologic surgeon and researcher whose work centers on advancing minimally invasive reconstructive techniques, particularly for complex ureteral and renal pathologies. His major contributions include pioneering comparative studies on ureteroplasty using buccal mucosa grafts, demonstrating that both open and robotic approaches yield high success rates for managing long proximal ureteral strictures—a notoriously challenging condition. Notably, his 2024 two-center comparison (13 citations) established that the robotic approach significantly reduces intraoperative blood loss while maintaining efficacy, offering a less invasive alternative for patients. Engelmann is also leading efforts to optimize surgical access in nephron-sparing surgery through the ROPARN feasibility trial (2025, 9 citations), which rigorously compares retroperitoneal versus transperitoneal robot-assisted partial nephrectomy. This randomized controlled study aims to confirm whether the retroperitoneal route provides time advantages and reduced peri-operative morbidity without compromising oncological outcomes. His work directly addresses critical gaps in urologic oncology and reconstruction, providing evidence-based guidance for surgical decision-making. With a growing citation impact, Engelmann is shaping the future of robotic urology by validating techniques that minimize patient trauma while maximizing surgical precision.